Clinical Utility of Urinary Antigen Detection for Diagnosis of Community-Acquired, Travel-Associated, and Nosocomial Legionnaires' Disease-Reference-Cited by-同舟云学术

Clinical Utility of Urinary Antigen Detection for Diagnosis of Community-Acquired, Travel-Associated, and Nosocomial Legionnaires' Disease

Published:2003-02 Issue:2 Volume:41 Page:838-840
ISSN:0095-1137
Container-title:Journal of Clinical Microbiology
language:en
Short-container-title:J Clin Microbiol

Author:

Helbig Jürgen H.¹,Uldum Søren A.²,Bernander Sverker³,Lück Paul Christian¹,Wewalka Günther⁴,Abraham Bill⁵,Gaia Valeria⁶,Harrison Timothy G.⁷

Affiliation:

1. Institut Medizinische Mikrobiologie und Hygiene, Medizinische Fakultät TU Dresden, Dresden, Germany

2. Department of Respiratory Infections, Meningitis and STIs, Statens Serum Institut, Copenhagen, Denmark

3. Karolinska Hospital, Stockholm, Sweden

4. Bundesstaatliche Baktiologisch-serologische Untersuchungsanstalt, Vienna, Austria

5. Scottish Legionella Reference Laboratory, Stobhill Hospital, Glasgow, Scotland

6. Istituto Cantonale Batteriologico, Lugano, Switzerland

7. Respiratory and Systemic Infection Laboratory, PHLS Central Public Health Laboratory, London, United Kingdom

Abstract

ABSTRACT The clinical utility of Legionella urinary antigen assays for the diagnosis of Legionnaires' disease was assessed by using samples from 317 culture-proven cases. The sensitivities of the Binax enzyme immunoassay (EIA) and Biotest EIA were found to be 93.7 and 94.4% for travel-associated infection and 86.5 and 76.0% for community-acquired infection but only 44.2 and 45.7% for nosocomially acquired infection, respectively.

Publisher

American Society for Microbiology

Subject

Microbiology (medical)

Link

https://journals.asm.org/doi/pdf/10.1128/JCM.41.2.838-840.2003

Reference18 articles.

1. Evaluation of the Binax and Biotest Urinary Antigen Kits for Detection of Legionnaires' Disease Due to Multiple Serogroups and Species of Legionella

2. Craven, D. E., and K. A. Steger. 1997. Hospital-acquired pneumonia: perspectives for the healthcare epidemiologist. Infect. Control Hosp. Epidemiol.18:783-795.

3. Dennis, P. J., and J. V. Lee. 1988. Differences in aerosol survival between pathogenic and non-pathogenic strains of Legionella pneumophila serogroup 1. J. Appl. Bacteriol.65:135-141.

4. Dournon, E. W., F. Bibb, P. Rjagopalan, N. Desplaces, and R. M. McKinney. 1988. Monoclonal antibody reactivity as a virulence marker for Legionella pneumophila serogroup 1 strains. J. Infect. Dis.157:496-501.

5. Ehret, W., B. U. von Specht, and G. Ruckdeschel. 1986. Discrimination between clinical and environmental strains of Legionella pneumophila by a monoclonal antibody. Isr. J. Med. Sci.22:715-723.

Cited by 129 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of Polymerase Chain Reaction–High-Resolution Melt Assay for Waterborne Pathogens Legionella pneumophila, Vibrio parahaemolyticus, and Camplobacter jejuni;Microorganisms;2024-07-03

2. Severe Legionnaires’ disease;Annals of Intensive Care;2024-04-02

3. Microbiology of Severe Community-Acquired Pneumonia and the Role of Rapid Molecular Techniques;Seminars in Respiratory and Critical Care Medicine;2024-01-09

4. Early discontinuation of combination antibiotic therapy in severe community-acquired pneumonia: a retrospective cohort study;BMC Infectious Diseases;2023-09-18

5. Plasma Microbial Cell-Free DNA Sequencing from over 15,000 Patients Identified a Broad Spectrum of Pathogens;Journal of Clinical Microbiology;2023-07-13